Chapter 3 Candida
In this book, we discuss the changing medical and public profile of fungal infections in the period 1850–2000. We consider four sets of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or candidiasis (infection with Candida albicans); endemic, geographically specific infections in Nor...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Online |
| Idioma: | anglès |
| Publicat: |
Springer Nature
2021
|
| Matèries: | |
| Accés en línia: | 1000002 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
| _version_ | 1869526756456660992 |
|---|---|
| author | Homei, Aya Worboys, Michael |
| author_browse | Homei, Aya Worboys, Michael |
| author_facet | Homei, Aya Worboys, Michael |
| author_sort | Homei, Aya |
| collection | Directory of Open Access Books |
| description | In this book, we discuss the changing medical and public profile of fungal infections in the period 1850–2000. We consider four sets of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or candidiasis (infection with Candida albicans); endemic, geographically specific infections in North America (coccidioidomycosis, blastomycosis and histoplasmosis) and mycotoxins; and aspergillosis (infection with Aspergillus fumigatus). We discuss each disease in relation to developing medical knowledge and practices, and to social changes associated with ‘modernity’. Thus, mass schooling provided ideal conditions for the spread of ringworm of the scalp in children, and the rise of college sports and improvement of personal hygiene led to the spread of athlete’s foot. Antibiotics seemed to open the body to more serious Candida infections, as did new methods to treat cancers and the development of transplantation. Regional fungal infections in North America came to the fore due to the economic development of certain regions, where population movement brought in non-immune groups who were vulnerable to endemic mycoses. Fungal toxins or mycotoxins were discovered as by-products of modern food storage and distribution technologies. Lastly, the rapid development and deployment of new medical technologies, such as intensive care and immunosuppression in the last quarter of the twentieth century, increased the incidence of aspergillosis and other systemic mycoses. |
| format | Online |
| id | doab-20.500.12854ir-25992 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Springer Nature |
| publisherStr | Springer Nature |
| record_format | ojs |
| spelling | doab-20.500.12854ir-259922025-07-30T09:00:23Z Chapter 3 Candida Homei, Aya Worboys, Michael candidiasis mycotoxins aspergillosis fungal infections dermatophytosis thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders In this book, we discuss the changing medical and public profile of fungal infections in the period 1850–2000. We consider four sets of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or candidiasis (infection with Candida albicans); endemic, geographically specific infections in North America (coccidioidomycosis, blastomycosis and histoplasmosis) and mycotoxins; and aspergillosis (infection with Aspergillus fumigatus). We discuss each disease in relation to developing medical knowledge and practices, and to social changes associated with ‘modernity’. Thus, mass schooling provided ideal conditions for the spread of ringworm of the scalp in children, and the rise of college sports and improvement of personal hygiene led to the spread of athlete’s foot. Antibiotics seemed to open the body to more serious Candida infections, as did new methods to treat cancers and the development of transplantation. Regional fungal infections in North America came to the fore due to the economic development of certain regions, where population movement brought in non-immune groups who were vulnerable to endemic mycoses. Fungal toxins or mycotoxins were discovered as by-products of modern food storage and distribution technologies. Lastly, the rapid development and deployment of new medical technologies, such as intensive care and immunosuppression in the last quarter of the twentieth century, increased the incidence of aspergillosis and other systemic mycoses. 2021-02-10T12:58:18Z 2020-03-18 13:36:15 2020-04-01T12:40:36Z 2014-05-07 23:55 2020-03-18 13:36:15 2020-04-01T12:40:36Z 2013 chapter 1000002 OCN: 1076696903 http://library.oapen.org/handle/20.500.12657/29952 https://directory.doabooks.org/handle/20.500.12854/25992 eng Science, Technology and Medicine in Modern History open access image/jpeg image/jpeg image/jpeg image/jpeg n/a n/a n/a n/a https://library.oapen.org/bitstream/20.500.12657/29952/1/Candida%20-%20Fungal%20Disease%20in%20Britain%20and%20the%20United%20States%201850%e2%80%932000%20-%20NCBI%20Bookshelf.pdf https://library.oapen.org/bitstream/20.500.12657/29952/1/Candida%20-%20Fungal%20Disease%20in%20Britain%20and%20the%20United%20States%201850%e2%80%932000%20-%20NCBI%20Bookshelf.pdf https://library.oapen.org/bitstream/20.500.12657/29952/1/Candida%20-%20Fungal%20Disease%20in%20Britain%20and%20the%20United%20States%201850%e2%80%932000%20-%20NCBI%20Bookshelf.pdf https://library.oapen.org/bitstream/20.500.12657/29952/1/Candida%20-%20Fungal%20Disease%20in%20Britain%20and%20the%20United%20States%201850%e2%80%932000%20-%20NCBI%20Bookshelf.pdf Springer Nature Palgrave Macmillan 9fa3421d-f917-4153-b9ab-fc337c396b5a Fungal Disease in Britain and the United States 1850–2000 Wellcome Trust d859fbd3-d884-4090-a0ec-baf821c9abfd Wellcome Palgrave Macmillan 225 Basingstoke 074971 open access |
| spellingShingle | candidiasis mycotoxins aspergillosis fungal infections dermatophytosis thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders Homei, Aya Worboys, Michael Chapter 3 Candida |
| title | Chapter 3 Candida |
| title_full | Chapter 3 Candida |
| title_fullStr | Chapter 3 Candida |
| title_full_unstemmed | Chapter 3 Candida |
| title_short | Chapter 3 Candida |
| title_sort | chapter 3 candida |
| topic | candidiasis mycotoxins aspergillosis fungal infections dermatophytosis thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders |
| topic_facet | candidiasis mycotoxins aspergillosis fungal infections dermatophytosis thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders |
| url | 1000002 |
| work_keys_str_mv | AT homeiaya chapter3candida AT worboysmichael chapter3candida |